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and identified a new DNA target site for the five transcription factors 
from M. loti. The new target sequence is located at -35 bp from the start 
codon of the M. loti gene called exoy encoding a crucial enzyme for 
exopolysaccharide (EPS) production. Biosynthesis of  EPS are strictly 
connected with biofilm formation. Furthermore, we show, for the first 
time, the biofilm formation of M. loti and the attachment and detachment 
stages.
O8.4
LSD1 mediates MYCN control of epithelial-
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metastatic suppressor NDRG1 gene
S. Ambrosio1, C. Saccà1, S. Amente2, S. Talamo1, F. Gorini1, M. 
Capasso2, L. Lania2, B. Majello1
1Dept of Biology, University of Naples Federico II, Naples, Italy, 2 Dept 
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Neuroblastoma (NB) with MYCN amplification is a highly metastatic 
tumor in children, and unraveling the key players involved in MYCN-
induced invasion may identify new targets for therapy. Recently, we 
reported that Lysine Specific Demethylase 1 LSD1/KDM1A can form 
a tight complex with MYCN and this complex controls transcription 
of genes involved in MYCN-driven oncogenesis, proposing LSD1 as 
candidate therapeutic target in NB. RNA sequencing of NB cells treated 
with pharmacological LSD1 inhibitor (TCP) or LSD1 knockdown 
indicates that LSD1 affects Epithelial-mesenchymal transition (EMT) 
pathway, and we identify the metastatic suppressor N-myc down 
regulated gene 1 (NDRG1), a potent metastasis suppressor, as a direct 
LSD1 target. We found that LSD1 co-localizes with MYCN at the 
promoter region of the NDRG1 gene and inhibits its expression; LSD1 
knock down re-activates NDRG1 gene expression, with concomitant 
block of motility and invasiveness of NB cells. Our data suggest that 
LSD1 pharmacological targeting by small molecules could modulate 
invasiveness of cancer cells and knock down the ability of MYCN-
amplified Neuroblastomas to metastasize, through NDRG1 de-
repression.
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5-FU targets rpL3 to induce mitochondrial 
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A. Russo,V. Pagliara, A. Saide, E. Mitidieri, R. d’Emmanuele di Villa 
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Recent findings revealed in cancer cells novel stress response pathways, 
which in response to many chemotherapeutic drugs causing nucleolar 
stress, will function independently from tumor protein p53 (p53) and 
still lead to cell cycle arrest and/or apoptosis. Since it is known that 
most cancers lack functional p53, it is of great interest to explore 
these emerging molecular mechanisms. Here, we demonstrate that 
nucleolar stress induced by 5-fluorouracil (5-FU) in colon cancer cells 
devoid of p53 leads to the activation of ribosomal protein L3 (rpL3) as 
proapoptotic factor. rpL3, as ribosome-free form, is a negative regulator 
of cystathionine-β-synthase (CBS) expression at transcriptional 
level through a molecular mechanism involving Sp1. The rpL3-CBS 
association affects CBS stability and, in addition, can trigger CBS 
translocation into mitochondria. Consequently apoptosis will be induced 
through the mitochondrial apoptotic cell death pathway characterized by 
an increased ratio of Bax to Bcl-2, cytochrome c release and subsequent 
caspase activation. It is noteworthy that silencing of CBS is associated 
to a strong increase of 5-FU-mediated inhibition of cell migration and 
proliferation. These data reveal a novel mechanism to accomplish p53-
independent apoptosis and suggest a potential therapeutic approach 
aimed at upregulating rpL3 for treating cancers lacking p53.
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The 8-oxo-7.8-dihydro-2’-deoxyguanine (8-oxodG) is one of the 
major  oxidative modifications occurring to DNA coming from ROS-
producing cell activities. There are constitutively several thousand 
residues of 8-oxodG in the nuclear genome of human tissues and cultured 
cells, however the genomic distribution has not yet fully characterized. 
Here, we applied a novel method named OxyDIP-Seq to analyze the 
genome-wide distribution of 8-oxodG at a single nucleotide level, using 
next-generation high-throughput sequencing technology. We mapped 
8-oxodG distribution in human non-tumorigenic epithelial breast cell line 
MFC10A and querying 8-oxodG profiles for multiple genomic features. 
We found a non-stochastic distribution of DNA oxidation in the genome, 
rather a peculiar correlation between 8-oxodG residues and Polymerase 
II (Pol-II) coding genes was observed. We determined that spontaneous 
residues of 8-oxodG occur preferentially at gene body of Pol-II active 
genes. Moreover, ChIP-Seq analysis of gH2AX and NBS1 showed a 
peculiar overlapping between 8-oxodG, gH2AX and NBS1. Indeed, we 
found accumulation of 8-oxodG, gH2AX and NBS1 expecially in long, 
transcribed and late-replicating genes. Our characterization of genome 
distribution of 8-oxodG reveals a rationale of gene fragility and suggests 
a potential mechanism linking transcription and DNA breaks.
